Johnson & Johnson and its subsidiaries will pay more than $2.2 billion – one of the largest health-care fraud settlements in history – to settle criminal and civil liabilities arising from marketing of Risperdal and its injectable version, Invega, for uses not approved by the FDA. J&J admitted to inappropriate promotion of Risperdal to treat elderly, non-schizophrenic patients for symptoms such as anxiety, agitation, depression, hostility and confusion. “The conduct at issue in this case jeopardized the health and safety of patients and damaged the public trust,” said Attorney General Eric Holder.
Article →
Of further interest:
Johnson & Johnson to Settle Risperdal Improper Marketing Case (NY Times)
Johnson & Johnson to pay $2.2B in U.S. health care fraud settlement (CBS News)
Johnson & Johnson $2.2B settlement over marketing Risperdal, Invega and Natrecor (Fox)
J&J fined $2.2 bn for faulty drug claims, kickbacks (Google)
Of further interest:
Johnson & Johnson to Settle Risperdal Improper Marketing Case (NY Times)
Johnson & Johnson to pay $2.2B in U.S. health care fraud settlement (CBS News)
Johnson & Johnson $2.2B settlement over marketing Risperdal, Invega and Natrecor (Fox)
J&J fined $2.2 bn for faulty drug claims, kickbacks (Google)
But the drug companies aren’t responsible. Really, they aren’t. They marketed a product that was ILLEGAL to buy or possess without a PRESCRIPTION! Why is nobody going after the doctors?
Report comment
The doctors were “misled” (lied to). See below.
The settlement won’t resolve suits brought by attorneys general in Arkansas, Louisiana and South Carolina, where the company has appealed or has said it will appeal judgments over Risperdal sales.
Judges or juries in those states have ordered J&J to pay a total of about $1.8 billion in damages and fines over Risperdal marketing campaigns that were found to have misled doctors and patients about the drug’s health risks and effectiveness.
See http://www.bloomberg.com/news/2013-11-04/j-j-settlement-over-risperdal-said-to-be-announced-today.html
This whole Risperdal thing started real dirty,
An influential Harvard child psychiatrist told the drug giant Johnson & Johnson that planned studies of its medicines in children would yield results benefiting the company, according to court documents dating over several years that the psychiatrist wants sealed.
Dr. Joseph Biederman
The psychiatrist, Dr. Joseph Biederman, outlined plans to test Johnson & Johnson’s drugs in presentations to company executives. One slide referred to a proposed trial in preschool children of risperidone, an antipsychotic drug made by the drug company. The trial, the slide stated, “will support the safety and effectiveness of risperidone in this age group.”
Dr. Biederman was the lead author of a trial published last year concluding that treatment with risperidone improved symptoms of attention deficit and hyperactivity disorder in bipolar children.
Dr. Biederman — who was director of the Johnson & Johnson Center for Pediatric Psychopathology Research at Massachusetts General Hospital, in Boston — is in the middle of two controversies: one involves the use of antipsychotic drugs in children, and the other relates to conflicts of interest in medicine.
He is the world’s most prominent advocate of diagnosing bipolar disorder in even the youngest children and of using antipsychotic medicines to treat the disease, but much of his work has been underwritten by drug makers for whom he privately consults. An inquiry by Senator Charles E. Grassley, Republican of Iowa, revealed last year that Dr. Biederman earned at least $1.6 million in consulting fees from drug makers from 2000 to 2007 but failed to report all but about $200,000 of this income to university officials.
See http://www.nytimes.com/2009/03/20/us/20psych.html?_r=0
He kept the 1.6 million dollars and wrote this “apology letter” that doesn’t even say sorry ! Read it, Check it out !
http://web.archive.org/web/20110708110602/http://freepdfhosting.com/ce3f1b1ea1.pdf
More
The Money Trail in the J&J Risperdal/Biederman Case
November 25, 2008, 9:07 AM
Like a car crash in slow motion, the years that drug companies have spent encouraging the idea that disruptive children ought to be medicated are resulting in ever more lurid revelations in the business press. Yesterday evening came news that a suit against Johnson & Johnson regarding its drug Risperdal was filled with documents describing $6.4 million that J&J spent to popularize the idea that it is acceptable to give atypical antipsychotics to children, off-label. (Risperdal is the fourth most-used off-label drug in the U.S.) The suit was filed by parents claiming that the drugs damaged their children and should never have been prescribed. The FDA recently heard advice that these drugs are overprescribed.
At the center of many of these allegations is Dr. Joseph Biederman of Harvard, who ran a research center funded by J&J into Pediatric Psychopathology Research Center. As the Times notes:
Dr. Biederman’s work helped to fuel a fortyfold increase from 1994 to 2003 in the diagnosis of pediatric bipolar disorder and a rapid rise in the use of powerful, risky and expensive antipsychotic medicines in children.
To give you an idea of how much cash J&J made available to Biederman in pursuit of this goal, here’s a summary of the money J&J gave to Biederman, and others, as it promoted antipsychotic drugs for children in the early part of the decade. The dates refer to emails in which the information is contained. (The original documents can be seen here):
November 1999: $3,000 for a program at UConn, because “Dr. Biederman is not someone to jerk around–he has a very short fuse– he has enough projects with Lilly to keep his entire group busy for years.”
2002: J&J sponsored $224,670 worth of various studies.
March 2002: 1,000 doctors attend a $700 CME course given by Biederman, where Biederman was not “perceived to be aligned with any company in particular.”
July 2, 2002: $369,000 for a Risperdal study.
July 10, 2002: $55,000 check for Biederman processed.
Oct. 21, 2002: KOLs paid $2,500 to attend “National Child and Adolescent Advisory Board.”
Nov. 12 , 2002: Biederman receives another $200,000 in funding.
Dec. 12, 2002: Grant for $181,500 for a Biederman study.
2003 business plan: $1.8 million for a “branded pediatric educational institute” and $2.1 million for KOL advisory boards to gain support for adolescent labeling with the FDA.
2003: Grant money available rises to $300,000.
2003: Biederman demands reimbursement for $100,000 of drugs dispensed to him from a pharmacy.
2002/2003: Selling/Marketing and Medical Affairs budget for Mass. General Hospital at $631,000 and $345,000 for 2002 and YTD 2003, respectively.
2003: J&J Pediatric Psychopathology Research Center funds rise to $425,000.
2004: $500,000 paid to pediatric research center.
http://www.cbsnews.com/8301-505123_162-42840230/the-money-trail-in-the-j038j-risperdalbiederman-case/
Report comment
That is exactly what I am afraid is being allowed to happen. The doctors, who have the ultimate responsibility for what they do, are just going to point at the drug companies and walk away.
The doctors most certainly should have known. We’ve been practically screaming this stuff from the roof tops for decades. Every psychiatrist has probably been referred to the brain damage studies a hundred times in their careers, and of course they were all aware of Peter Breggin.
Drug companies cannot prescribe drugs. That is the doctors responsibility. When a doctor prescribes drugs that hurt people, they are the ones who caused the harm, not the drug companies.
If our government treated gun violence the way they treat psychiatric drugs, they’d sue the gun manufacturers for yearly gun violence while letting the killers go free.
Report comment
Drug companies and doctors, especially psychiatry are 2 parts of the same machine.
But I guess your right, that SOB doctor that handed me a sample of Zyprexa after my complaints of insomnia and said “don’t worry its safe” knew very well it wasn’t very safe and lied even if the makers buried evidence that it was very very unsafe, see below.
http://www.zyprexa-victims.com/
http://www.cbsnews.com/8301-505123_162-42844003/lilly-powerpoint-execute-the-038-out-of-them-a-photo-gallery-of-dodgy-drug-sales-advice/
More
http://i.bnet.com/blogs/spielmans-parry-ebm-to-mbm-jbioethicinqu-2010.pdf
Report comment
Wait what ? No one goes to prison ?
NO ONE GOES TO PRISON !!!!!!!
WHAT ??!!!
Report comment
“health-care fraud”
“The conduct at issue in this case jeopardized the health and safety of patients”
No one goes to prison.
Report comment
When the lawsuits roll in from the families of sick and dead patients, simply use a small portion of your windfall profits to pay a fine.
No one goes to prison.
Report comment
Look at this,
http://www.google.com/search?q=“risperdal+lawsuit”+NAMI+national+alliance+on+mental+illness
Click it , try searching “Risperdal Lawsuit” + NAMI
The pharma front group posing as advocates as usual are silent.
Lets try an old one Zyprexa + NAMI ,http://www.google.com/search?q=“Zyprexa+lawsuit”+NAMI+national+alliance+on+mental+illness
Again NAMI the phony advocates for the mentally ill say NOTHING online anyone can find.
“health-care fraud” AOK with NAMI the pharma front group.
Report comment
http://www.google.com/search?q=NAMI+Risperdal+lawsuit
The quotes messed up the post.
Report comment
Copy-cat, I’m currently reading Gary Greenberg’s “The Book of Woe – The DSM & the Unmaking of Psychiatry.” Greenberg refers to Biederman being questioned about his university position. Biederman states that he holds a very influential post, to which he was asked “And what’s higher than that?” and Biederman answers “God.” Greenberg rightly notes that this is a very strange response from a man who has devoted his career to pushing a disease, the symptoms of which include grandiosity.
Report comment
As much as I hate biederman, that quote of his has been completely misinterpreted. What he’s saying is that while he may have no earthly superior (At Harvard), that he answers to a higher power. It’s obvious he’s trying to suggest that he has morals.
If it were grandiosity, he would have just said “no one.”
Report comment
Okay, you’re right but the smug way he says that’s he at the top of the ladder at Harvard is still revealing. Pointing to your religion as proof that you have morals is not a convincing argument.
Report comment
I meant to type “smug way he says that he’s at the top ….”
Report comment
Biederman was the recipient of the 1998 NAMI ” national alliance on mental illness” Exemplary Psychiatrist award.
Dr. Joseph ‘Risperdal’ Biederman was caught red-handed lying about $1.6 million in drug money for performing medical experiments on children.
He kept all the money and wrote this “apology letter”
http://web.archive.org/web/20110708110602/http://freepdfhosting.com/ce3f1b1ea1.pdf
What’s adorable about Risperdal is how it’s marketed. What child can resist free legos? Risperdal puts legos stamped with the word RISPERDAL in pediatricians offices!
http://www.google.com/search?q=Risperdal+legos
Risperdal legos
Report comment
What Killed Rebecca Riley?
Rebecca Riley was four years old when she died from an overdose of medications given to her for “bipolar disorder”. As Katie Couric reports, bipolar disorder is a burgeoning diagnosis in children, but critics question the trend – and the safety of the drugs prescribed.
http://www.cbsnews.com/video/watch/?id=7380017n
$2.5 Million Settlement in Wrongful Death of Rebecca Riley against Psychiatrist
http://isepp.wordpress.com/2011/04/27/2-5-million-settlement-in-wrongful-death-of-rebecca-riley-against-psychiatrist/
How many kids lives did this Joseph Biderman and these pharma criminals destroy , how many thousands ?
And nobody goes to jail.
Hope they goto hell.
Report comment
The National Alliance For The Mentally Ill
Marketing Risperidone in 1996,
Risperidone for Adolescent Aggression
In a case report, control of aggression was achieved with risperidone therapy in six patients, aged eight to 14 years. All displayed aggressive behaviors that ranged from destructiveness to physical violence. Risperidone therapy produced dosage-related side effects in all six patients, but extrapyramidal side effects (resembling Parkinson’s disease) were avoided at dosages below 3mg/day in adolescents and 2mg/day in children.
–Medical Focus, Winter 1996
http://web.archive.org/web/19961221104126/http://www.nami.org/
http://web.archive.org/web/19961221104126/http://www.nami.org/
Report comment
Does anyone know the aggregate amount of awards and settlements paid by J&J to individuals who had taken Risperdal for off label indications and were injured as a consequence?
Report comment